Phospho-PGCA Blocking Peptide

General Information

Product

Phospho-PGCA Peptide

Description

Antigenic Blocking Peptide Atrial Natriuretic peptide receptor 1 Antibody

Verified Applications

Immunodepletion, Immunocompetition

Peptide Description

Synthetic peptide taken within amino acid region 500-550 on human Atrial natriuretic peptide receptor 1 protein.

Accession #

NCBI:  XP_011507887.1

Physical Properties

Quantity

250 µg

Volume

100 µl

Form

Antigenic Blocking Peptide

Storage

-20⁰C for long term storage

Application Protocol

Competition/Depletion assay

Refer to competition assay protocol

Protein

Uniprot #

P16066

Overview

Receptor for the atrial natriuretic peptide NPPA/ANP and the brain natriuretic peptide NPPB/BNP which are potent vasoactive hormones playing a key role in cardiovascular homeostasis. Has guanylate cyclase activity upon binding of the ligand.

Molecular Function

ATP binding, GTP binding, hormone binding, Protein kinase activity, G-protein coupled peptide receptor activity

Subcellular Location

Membrane; Single-pass type I membrane protein

Structure

Homodimer

Alternative Nomenclature

ANP A antibody

ANPR-A antibody

Atrial natriuretic peptide A type receptor antibody

Atrial natriuretic peptide receptor 1 antibody

Atrionatriuretic peptide receptor A antibody

GC A antibody

Guanylate cyclase A antibody

Guanylate cyclase antibody

GUC2A antibody

Natriuretic peptide A type receptor antibody

Natriuretic peptide receptor A/guanylate cyclase A antibody

NPR 1 antibody

NPR A antibody